Document Detail


Use of the GlucoWatch biographer in children with type 1 diabetes.
MedLine Citation:
PMID:  12671113     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine whether use of the GlucoWatch biographer improves glucose control in children and adolescents with type 1 diabetes. METHODS: Forty children in poor glucose control (glycohemoglobin [HbA1c] >8%) were randomized to diabetes management with or without glucose monitoring using the biographer. Conventional glucose monitoring was performed 4 times daily in both groups. Those randomized to the biographer group were asked to wear the device 4 times per week for 3 months (intervention phase) and to perform blood glucose monitoring if the biographer alerted them that glucose was < or =70 mg/dL (3.9 mmol/L) or > or =300 mg/dL (16.7 mmol/L). After 3 months, all patients received biographers and were followed for 6 months (observation phase). HbA1c values were determined at baseline and after 1, 3, 6, and 9 months. RESULTS: The median HbA1c was 8.6% and 8.9% (control versus biographer) at baseline and was significantly lower in the biographer group after 3 months (8.4% vs 9%). More hypoglycemia was detected when subjects were wearing the biographer, especially at night. No severe hypoglycemia occurred. During the observation phase, HbA1c values at 6 months were 8.5% and 8.3% and at 9 months were 8.6% and 8.4% in the control and biographer groups, respectively. Two children dropped out of the study, 1 because of skin irritation from using the device. CONCLUSIONS: The GlucoWatch biographer was well tolerated by children and adolescents and significantly improved glucose control compared with standard therapy. The use of the biographer with an alarm to detect nocturnal hypoglycemia has the potential to increase the safety of diabetes management in children.
Authors:
H Peter Chase; Mary D Roberts; Clare Wightman; Georgeanna Klingensmith; Satish K Garg; Michelle Van Wyhe; Shashi Desai; Wesley Harper; Margarita Lopatin; Miroslaw Bartkowiak; Janet Tamada; Richard C Eastman
Related Documents :
2974783 - Optimizing blood glucose control in type 2 diabetes: an approach based on fasting blood...
17591623 - Impact of self monitoring of blood glucose in the management of patients with non-insul...
17412323 - Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pediatrics     Volume:  111     ISSN:  1098-4275     ISO Abbreviation:  Pediatrics     Publication Date:  2003 Apr 
Date Detail:
Created Date:  2003-04-02     Completed Date:  2003-04-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  790-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Blood Glucose Self-Monitoring / instrumentation*,  methods*
Child
Diabetes Mellitus, Type 1 / blood*,  drug therapy,  urine
Female
Glucose / metabolism
Hemoglobin A, Glycosylated / metabolism
Hemoglobinuria / metabolism
Humans
Hypoglycemia / chemically induced
Infusion Pumps, Implantable
Injections, Subcutaneous
Insulin / administration & dosage,  therapeutic use
Insulin Infusion Systems
Male
Quality of Life
Chemical
Reg. No./Substance:
0/Hemoglobin A, Glycosylated; 11061-68-0/Insulin; 50-99-7/Glucose
Comments/Corrections
Comment In:
Pediatrics. 2003 Apr;111(4 Pt 1):885   [PMID:  12671127 ]
Pediatrics. 2004 Jan;113(1 Pt 1):175-6; author reply 175-6   [PMID:  14702477 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis.
Next Document:  Nighttime child care: inadequate sudden infant death syndrome risk factor knowledge, practice, and p...